Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, ...

Craft Capital Management LLC acted as underwriter for the Offering (the “Underwriter”). VCL Law LLP acted as U.S. securities counsel to the Company, and Ortoli Rosenstadt LLP acted as U.S. securities ...

Tainan, Taiwan, March 06, 2025 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, diagnosis ...

Advanced Biomed Inc. (ADVB) expects to raise $10 million in an initial public offering (IPO) on the week of February 24th, IPO Scoop reports. The company will be issuing 1,900,000 shares at $4.00 ...

DSS, Inc. (NYSE American: DSS), a multinational company focused on innovation-driven business models, today announced the ...

Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

CLS-AX Phase 3 Program Designed to Maximize Commercial Potential in Wet AMD -- Flexible Dosing and Extended Duration would be Important ...

The global meningitis treatment industry, valued at USD 150.9 million in 2023, is projected to grow at a CAGR of 4.1% from ...

Q4 2024 Earnings Call Transcript March 4, 2025 InfuSystem Holdings, Inc. misses on earnings expectations. Reported EPS is ...

Soligenix (SNGX) , a late-stage biopharmaceutical company focused on rare diseases, announced that its lead investigators will present findings from ...